Camtek holder plans sale of 6,387 ordinary shares

A shareholder of Camtek Ltd. filed to potentially sell 6,387 Ordinary Shares, with an aggregate market value of $1,112,615.40, on or after August 13, 2026 through Oppenheimer & Co. Inc. on Nasdaq.

Rhea-AI Filing Summary

A shareholder of Camtek Ltd. filed to potentially sell 6,387 Ordinary Shares, with an aggregate market value of $1,112,615.40, on or after August 13, 2026 through Oppenheimer & Co. Inc. on Nasdaq. The filing also lists prior Ordinary Shares issued upon vesting of RSUs on January 16, 2024 (12,701 shares) and April 1, 2025 (2,872 and 1,701 shares) for no cash consideration.

Key Figures

Shares to be sold: 6,387 shares Aggregate market value: $1,112,615.40 Shares outstanding: 45,828,133 shares +4 more

7 metrics

Shares to be sold 6,387 shares Ordinary Shares proposed for sale through Oppenheimer & Co. Inc.

Aggregate market value $1,112,615.40 Market value of 6,387 Ordinary Shares covered by the planned sale

Shares outstanding 45,828,133 shares Ordinary Shares outstanding for Camtek Ltd.

Earliest sale date 08/13/2026 Date from which the 6,387 shares may be sold

RSU vesting issuance 12,701 shares Ordinary Shares issued upon vesting of RSUs on 01/16/2024

RSU vesting issuance 2,872 shares Ordinary Shares issued upon vesting of RSUs on 04/01/2025

RSU vesting issuance 1,701 shares Ordinary Shares issued upon vesting of RSUs on 04/01/2025

Key Terms

Ordinary Shares, RSUs, aggregate market value, Nasdaq

4 terms

Ordinary Shares financial

"Ordinary Shares | Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

RSUs financial

"Shares issued upon vesting of RSUs | CAMTEK LTD"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

aggregate market value financial

"6387 | 1112615.40 | 45828133 | 08/13/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Nasdaq market

"45828133 | 08/13/2026 | Nasdaq"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sale is being planned for Camtek Ltd. (CAMT)?

A shareholder plans a potential sale of 6,387 Camtek Ordinary Shares with an aggregate market value of $1,112,615.40. The shares may be sold through Oppenheimer & Co. Inc. on or after August 13, 2026 on Nasdaq.

Which broker is handling the planned Camtek (CAMT) share sale?

The planned sale of 6,387 Camtek Ordinary Shares is to be executed through Oppenheimer & Co. Inc., located at 85 Broad St., New York, NY 10004. The shares are listed for trading on Nasdaq.

What is the value of Camtek (CAMT) shares covered by this planned sale?

The filing covers 6,387 Camtek Ordinary Shares with an aggregate market value of $1,112,615.40. The filing also notes 45,828,133 Ordinary Shares as outstanding, providing context for the size of the potential sale.

What RSU vesting-related issuances are disclosed for Camtek Ltd. (CAMT)?

The document lists Ordinary Shares issued upon RSU vesting: 12,701 shares on January 16, 2024, and 2,872 and 1,701 shares on April 1, 2025. All were issued for no cash consideration upon vesting of RSUs.

How many Camtek (CAMT) shares are shown as outstanding in this content?

The content cites 45,828,133 Ordinary Shares as outstanding. This figure serves as a baseline for understanding the relative size of the 6,387-share potential sale described in the document.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2026 - 06:15 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001973443
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CAMTEK LTD
SEC File Number	000-30664
Address of Issuer	INDUSTRIAL ZONE PO BOX 544 MIGDAL HAEMEK ISRAEL 23150
Phone	972-4-604-8100
Name of Person for Whose Account the Securities are To Be Sold	Langer Ram
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	6387	1112615.40	45828133	08/13/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	01/16/2024	Shares issued upon vesting of RSUs	CAMTEK LTD			12701	01/16/2024	No consideration, shares issued upon vesting of RSUs
Ordinary Shares	04/01/2025	Shares issued upon vesting of RSUs	CAMTEK LTD			2872	04/01/2025	No consideration, shares issued upon vesting of RSUs
Ordinary Shares	04/01/2025	Shares issued upon vesting of RSUs	CAMTEK LTD			1701	04/01/2025	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Ram Langer By: /s/ Meirav Shemesh Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)